DECLARE-TIMI58
Phase 3
Completed
- Conditions
- Diabetes Mellitus, Non-Insulin-Dependen High Risk for Cardiovascular Event
- Registration Number
- JPRN-jRCT2080222423
- Lead Sponsor
- AstraZeneca KK
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 17150
Inclusion Criteria
Provision of informed consent prior to any study specific procedures
- Diagnosed with Type 2 Diabetes
- High Risk for Cardiovascular events
Exclusion Criteria
- Diagnosis of Type 1 diabetes mellitus History of bladder cancer or history of radiation therapy to the lower abdomen or pelvis at any time
- Chronic cystitis and/or recurrent urinary tract infections
- Pregnant or breast-feeding patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method